Image

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Recruiting
15-24 years
All
Phase N/A

Powered by AI

Overview

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

Description

Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. Moreover, approximately three-quarters of anxious youth also report sleep-related problems. Literature reviews have investigated the relationship and the shared underlying mechanisms between sleep and anxiety. Anxiety sensitivity and pre-sleep arousal have been found to play a critical role in difficulty initiating sleep, which is the most common insomnia symptoms in adolescent population, partially due their natural delay of circadian rhythm. The findings suggest shared neurological and cognitive features that may account for dysregulation of both sleep and affect. Management targeting both sleep and anxiety is recommended due to potentially higher treatment efficacy and cost-effectiveness.

Accumulating evidence supports the effectiveness of cognitive-behavioural therapy for insomnia (CBT-I) and acceptance and commitment therapy (ACT) for addressing sleep and mood problems in adolescents. However, Only a few studies have directly compared the effectiveness of CBT-I and ACT. Past studies have shown that both CBT-I and ACT were effective in treating insomnia in adults.

This current study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth. The primary hypothesis is that subjects in CBT-I combined ACT will have fewer anxiety symptoms as compared to CBT-I at post-intervention and 3-month follow-up.

Eligibility

Inclusion Criteria:

Youth who meet the following criteria would be eligible for taking part in this trial:

        i. Chinese youth aged 15-24 years old, ii. Presence of insomnia problems as defined by
        insomnia severity index (ISI) using cut-off of 9, which has been locally validated cut off
        for detecting clinical insomnia), iii. Presence of anxiety features as defined by General
        Anxiety Disorder-7 (GAD-7) using cut-off of 10 for detecting clinical anxiety, iv. Ability
        to listen, speak, and read Chinese and Cantonese, and v. Written informed consent of
        participation into the study is given by youth and his/her parent's if under 18 years old;
        In addition, individual assent will also be obtained for subjects under age 18 years old
        vi. Possession of smartphone
        Exclusion Criteria:
        A youth would be excluded from the study if meeting one or more of the following criteria:
        i. A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual
        disability ii. Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy)
        that may potentially contribute to the disruption of sleep quantity and quality as
        determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP) iii.
        Having a clinically significant suicidality (presence of suicidal ideation with a plan or
        an attempt) as assessed by The Structured Clinical Interview (SCID) iv. Currently receiving
        psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.

Study details
    Insomnia
    Anxiety
    Youth

NCT06156306

Chinese University of Hong Kong

17 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.